Jonathan Zalevsky
NKTRJonathan Zalevsky serves as officer: Chief R&D Officer at Nektar Therapeutics (NKTR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Jonathan Zalevsky's Insider Trading at Nektar Therapeutics (NKTR)
Buys
0 · $0.00
Sells
26 · $2.07M
Total Shares Bought
0
Total Shares Sold
341,049